Relationship of hypoxia-inducible factor (HIF)-1α and HIF-2α expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines

Cancer Research

Volumn 60, Issue 24, 2000, Pages 7106-7113

  Blancher, Christine ^a   Moore, John W ^a   Talks, Kate L ^a   Houlbrook, Sue ^a   Harris, Adrian L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LACTATE DEHYDROGENASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME SUBUNIT; GENE CONTROL; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TRANSACTIVATION; TUMOR GROWTH;

ANIMALS; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL SURVIVAL; CELLS, CULTURED; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; ISOENZYMES; L-LACTATE DEHYDROGENASE; LYMPHOKINES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PHENOTYPE; RNA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034671256     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Antineoplastic drug resistance and breast cancer
2. Oxygen(es) and the hypoxia-inducible factor-I
3. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor L
4. 2 tension
5. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit
6. Hypoxia-inducible factor 1-α (HIF-1-α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions-its stabilization by hypoxia depends on redox-induced changes
7. Activation of hypoxia-inducible factor-1-definition of regulatory domains within the α-subunit
8. 2-dependent degradation domain via the ubiquitin-proteasome pathway
9. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
10. Hrf, a putative basic helix-loop-helix-pas-domain transcription factor is closely-related to hypoxia-inducible factor-1-α and developmentally expressed in blood vessels
11. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1-α regulates the VEGF expression and is potentially involved in lung and vascular development
12. Hypoxia-inducible factor-I modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
13. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
14. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 α-subunit (HIF-1-α)-characterization of HIF-1-α-dependent and HIF-1-α-independent hypoxia-inducible gene expression
15. 2 homeostasis by hypoxia-inducible factor 1-α
16. HIF-1-α is required for solid tumor formation and embryonic vascularization
17. Role of HIF-1-α in hypoxia-mediated apoptosis, cell-proliferation and tumor angiogenesis
18. 2 tension measurements
19. Improved RNase protection assay for quantifying LDL-receptor mRNA: Estimation of analytical imprecision and biological variance in peripheral blood mononuclear cells
20. Quantitative measurement of mRNA using the RNase protection assay
21. Recommended methods for the determination of four enzymes in blood
22. The role of retinoblastoma and p53 tumor suppressor pathways in human mammary epithelial cell immortalization
23. p53 Expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer
24. Estradiol/progesterone interaction in normal and pathologic breast cells
25. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture
26. Overexpression of the c-erbB-2 protein in human breast tumor cell lines
27. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
28. The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231
29. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice
30. A cell line (HBL-100) established from human breast milk
31. Induction of endothelial PAS domain protein-1 by hypoxia-characterization and comparison with hypoxia-inducible factor-1-α
32. The expression and distribution of the hypoxia inducible factors HIF-1a and HIF-2a in normal human tissues, cancer and tumor associated macrophages
33. The role of the aryl-hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression-studies in ARNT-deficient cells
34. Functional interference between hypoxia and dioxin signal transduction pathways-competition for recruitment of the ARNT transcription factor
35. Activation of hypoxia-inducible factor 1-α-posttranscriptional regulation and conformational change by recruitment of the ARNT transcription factor
36. V-src induces expression of hypoxia-inducible-factor-1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase-1-involvement of HIF-1 in tumor progression
37. Regulation of proliferation-survival decisions during tumor-cell hypoxia
38. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
39. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
40. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
41. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
42. Increased expression of hypoxia inducible factor-1α in rat and human prostate cancer
43. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker
44. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
45. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
46. Elevated expression of eIF4E in confined early breast cancer lesions: Possible role of hypoxia
47. Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E
48. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression
49. eIF4E expression in tumors: Its possible role in progression of malignancies
50. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression
51. Oncogenes in tumor metabolism, tumorigenesis, and apoptosis
52. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth
53. The role of multiple enzyme activation in metabolic flux control
54. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements